Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effects of Bacille Calmette-GuÉrin after the first demyelinating event in the CNS.
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Fine-Tuning S1P Therapeutics.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK.
Baló's Concentric Sclerosis in Multiple Sclerosis.
Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients.
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Use of a Time-of-Flight Camera With an Omek Beckon™ Framework to Analyze, Evaluate and Correct in Real Time the Verticality of Multiple Sclerosis Patients during Exercise.
[Non-medicinal treatments of spasticity in multiple sclerosis].
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders.
Mitochondrial dysfunction in central nervous system white matter disorders.
Active induction of experimental autoimmune encephalomyelitis by MOG35-55 peptide immunization is associated with differential responses in separate compartments of the choroid plexus.
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: A case control study.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Schwann cells in therapy of spinal cord injuries.
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
Pages
« first
‹ previous
…
231
232
233
234
235
236
237
238
239
…
next ›
last »